Tempest Therapeutics (NASDAQ:TPST) Research Coverage Started at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a report released on Thursday morning, Briefing.com reports. The brokerage issued a buy rating and a $15.00 target price on the stock. Separately, HC Wainwright lifted their target price on shares of Tempest Therapeutics from $35.00 to $47.00 and gave […]
More Stories
Blue Barn Wealth LLC Has $384,000 Position in Alphabet Inc. (NASDAQ:GOOGL)
Blue Barn Wealth LLC lowered its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 8.3% in the 1st quarter,...
Gemini Chatbot Got a New Update: Enhanced Memory with New Privacy Options
Google is coming up with new updates to its Gemini AI assistant that aim to make conversations more personal and...
PNC Financial Services Group Inc. Has $472,000 Stock Position in CAVA Group, Inc. (NYSE:CAVA)
PNC Financial Services Group Inc. raised its position in CAVA Group, Inc. (NYSE:CAVA – Free Report) by 123.4% during the...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by VeraBank N.A.
VeraBank N.A. decreased its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.8% during the 1st quarter,...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Arjuna Capital
Arjuna Capital lowered its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.6% in the 1st quarter, according to...
Alphabet Inc. (NASDAQ:GOOGL) Position Boosted by CenterBook Partners LP
CenterBook Partners LP boosted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 43.8% during the 1st...